And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to ... neuroscience leader with the drug’s manufacturer, Johnson & Johnson, said in a news release.

NEW YORK (WPIX) – The U.S ... The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

New York, April 30, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) applauds the U.S. Food and Drug Administration (FDA) approval ... this approval in Johnson & Johnson’s news ...

Health care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug ... felt primarily within the company's medical technology unit, which makes ...

Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and a former acting director of the CDC, recently praised the FDA's decision to have three vaccines made available for ...

Johnson & Johnson's recent FDA approval for IMAAVY could significantly bolster its product portfolio in autoimmune conditions, aligning well with the anticipated growth in their Innovative ...

A first-in-its-class diabetes drug by Johnson &amp, Johnson’s Janssen ... of Metabolism and Endocrinology Products in the FDA’s Center for Drug Evaluation and Research. Type 2 diabetes affects ...

New York, April 30, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) applauds the U.S. Food and Drug Administration (FDA) approval of IMAAVY TM ... Learn more about this approval in ...